Source:http://linkedlifedata.com/resource/pubmed/id/12064130
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:dateCreated |
2002-6-14
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0065-6895
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
51
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
413-28
|
| pubmed:dateRevised |
2011-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:12064130-Antineoplastic Agents,
pubmed-meshheading:12064130-Bone Neoplasms,
pubmed-meshheading:12064130-Chondrosarcoma,
pubmed-meshheading:12064130-Combined Modality Therapy,
pubmed-meshheading:12064130-Humans,
pubmed-meshheading:12064130-Osteosarcoma,
pubmed-meshheading:12064130-Prognosis,
pubmed-meshheading:12064130-Sarcoma, Ewing
|
| pubmed:year |
2002
|
| pubmed:articleTitle |
Malignant bone tumors.
|
| pubmed:affiliation |
Department of Orthopaedic Surgery, University of Colorado Health Sciences Center, Denver, Colorado, USA.
|
| pubmed:publicationType |
Journal Article,
Review
|